Halma acquires Dreampath Diagnostics to strengthen healthcare capabilities
The acquisition adds tissue sample traceability and archiving solutions for pathology labs.
See the latest news and media coverage for Halma. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global group of life-saving technology companies
halma.comLast updated
In short: Halma achieved consecutive years of record revenue and profit, driven by robust performance in its photonics unit and a series of strategic acquisitions.
The acquisition adds tissue sample traceability and archiving solutions for pathology labs.
It acquired itemedical (patient data platforms) and Naslund Medical (fiducial markers for cancer treatment).
Revenue exceeded £2.5 billion for the first time, up 15%, and adjusted profit grew 22% to £594.5m.
Revenue exceeded £2.5bn and adjusted profit over £500m for the first time, with broad-based growth across all sectors.
Halma stock reflects a mix of steady valuation and growth after the UK safety technology group delivered record revenue and profit in fiscal 2025 and...
Halma (OTCMKTS:HLMAF – Get Free Report) saw unusually-high trading volume on Thursday . 19,140 shares were traded during trading, an increase of 178% from the...
Investing.com - Bank of America reinstated coverage on Halma PLC (LON:HLMA) with a Buy rating and set a price target of 4,600 pence, citing approximately...
(Alliance News) - UK house prices edge higher in June, Halma buys French diagnostics firm Dreampath for an initial EUR154 million, while Shell expects lower...
Track Halma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.